KJ Bio A/S: Financial statements 2024
CVR: 40352104
Source: annual report 2024, Danish Business Authority
01/05/2023 – 30/04/2024
KJ Bio A/S (CVR 40352104) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -51,660 and a net result of DKK -106,521 compared with DKK -559,828 the year before. Equity in the 2024 report amounted to DKK -607,539.
- Gross Profit
- DKK -51,660
- Profit/Loss
- DKK -106,521
- Equity
- DKK -607,539
- Total Assets
- DKK 2,430
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -52K | -107K | -608K | 0 |
| 2023 | - | -135K | -560K | -501K | 1 |
| 2022 | - | -123K | -526K | 59K | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout KJ Bio A/S
KJ Bio A/S was a Danish company of the type Aktieselskab based in Hinnerup, founded in 2019. The company has been dissolved on 29 April 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named TGOD Genetics A/S. The company has 1 employee (2023). In 2024, the company reported a gross profit of DKK -51,660 and a net result of DKK -106,521 compared with DKK -559,828 the year before. Equity in the 2024 report amounted to DKK -607,539.